Search
Powered By HealthLine
Health Tools
 A-Z Symptoms
 Health Centers
 Check A Symptom
 Stress Test
 Health Library
Featured Conditions
 Caregiver
 Skin Care
 Food & Fitness
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Flomax

[Tamsulosin]

Effect of Food:

The time to maximum concentration (Tmax) is reached by four to five hours under fasting conditions and by six to seven hours when FLOMAX capsules are administered with food. Taking FLOMAX capsules under fasted conditions results in a 30% increase in bioavailability (AUC) and 40% to 70% increase in peak concentrations (Cmax) compared to fed conditions
(Figure 1).
Figure 1: Mean Plasma Tamsulosin HCI Concentrations Following Single-Dose Administration of FLOMAX capsules 0.4 mg Under Fasted and Fed

Conditions (n= 8)

Text Continues Below



The effects of food on the pharmacokinetics of tamsulosin HCI are consistent regardless of whether a FLOMAX capsule is taken with a light breakfast or a high-fat breakfast (Table 1).
TABLE 1 Mean (± S. D.) Pharmacokinetic Parameters Following FLOMAX capsules 0.4 mg Once Daily or 0.8 mg Once Daily with a Light Breakfast, High-Fat
Breakfast or Fasted Pharmacokinetic
Parameter 0. 4 mg q. d. to healthy volunteers; n= 33 (age range 18-32 years) 0.8 mg q. d. to healthy volunteers; n= 22 (age range 55-75 years) Light Breakfast Fasted Light Breakfast High-Fat Breakfast Fasted
Cmin (ng/ mL) 4.0 ± 2.6 3.8 ± 2.5 12.3 ± 6.7 13.5 ± 7.6 13.3 ± 13. 3 Cmax (ng/ mL)
10.1 ± 4.8 17.1 ± 17. 1 29.8 ± 10. 3 29.1 ± 11. 0 41.6 ± 15. 6 Cmax/ Cmin Ratio 3.1 ± 1.0 5.3 ± 2.2 2.7 ± 0.7 2.5 ± 0.8 3.6 ± 1.1

Tmax (hours) 6.0 4.0 7.0 6.6 5.0 T1/ 2 (hours) ----14.9 ± 3.9
AUC . (ng . hr/ mL) 151 ± 81. 5 199 ± 94. 1 440 ± 195 449 ± 217 557 ± 257 Cmin = observed minimum concentration
Cmax = observed maximum tamsulosin HCI plasma concentration Tmax = median time-to-maximum concentration
T1/ 2 = observed half-life AUC . = Area under the tamsulosin HCI plasma time curve over the dosing interval

Distribution:

The mean steady-state apparent volume of distribution of tamsulosin HCI after intravenous administration to ten healthy male adults was 16L, which is suggestive of distribution into extracellular fluids in the body. Additionally, whole body autoradiographic studies in mice and rats and tissue distribution in rats and dogs indicate that tamsulosin HCI is widely distributed to most tissues including kidney, prostate, liver, gall bladder, heart, aorta, and brown fat, and minimally distributed to the brain, spinal cord, and testes.

Page:  << Prev | 1 | 2 | 3 | 4 | 5 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire